Management of Ureteral Stents in PCN-Related Infections
Primary Management Strategy
- The American College of Radiology recommends starting empiric antibiotics immediately with ceftriaxone or ampicillin/sulbactam to cover expected uropathogens, which reduces serious sepsis-related complications from 50% to 9% in high-risk patients 1, 2
- Obtaining blood and urine cultures before initiating antibiotics is crucial, then adjusting therapy based on sensitivities, as recommended by the American College of Radiology 2
Device-Specific Considerations
- Internal double-J ureteral stents are particularly prone to infection, with reported rates of 11%, according to the American Cancer Society 1
- In patients with urinary diversions, double-J stents occlude quickly from mucous plugging and should be avoided in favor of percutaneous nephroureteral catheters, as suggested by the American College of Radiology 3, 4
Prevention Strategy
- The American College of Radiology recommends periodic reassessment of device necessity with removal when no longer required, as infection risk correlates directly with duration of placement 1, 2
- Using preprocedural antimicrobial prophylaxis with ceftriaxone or ampicillin/sulbactam is recommended for planned exchanges, according to the American Cancer Society 1, 2